MyFinsight
Home
Blog
About
Contact
Download
Download image
Marketable securities
$195,604K
Cash and cash
equivalents
$34,466K
Accounts receivable
$26,379K
Other current assets
$12,905K
Prepaid expenses
$11,927K
Total property and
equipment
$192,047K
Total current assets
$281,281K
Property and equipment,
net
$104,855K
Operating lease
right-of-use assets
$47,156K
Marketable securities
$10,785K
Other assets
$4,613K
Accounts receivable
$2,312K
Restricted cash
$2,030K
Accumulated depreciation
and amortization
$87,192K
Total assets
$453,032K
Total liabilities and
stockholders equity
$453,032K
Total liabilities
$350,299K
Total stockholders
equity
$102,733K
Accumulated deficit
-$1,126,027K
Accumulated other
comprehensive loss
-$687K
Royalty monetization
liabilities
$147,408K
Total current
liabilities
$118,095K
Operating lease
liabilities
$65,215K
Deferred revenue
$18,943K
Other liabilities
$638K
Additional paid-in capital
$1,229,442K
Common stock 0.0001 par
value 100,000 shares...
$5K
Royalty monetization
liabilities
$39,609K
Accrued expenses and
other current...
$38,390K
Accounts payable
$21,358K
Deferred revenue
$10,452K
Operating lease
liabilities
$8,286K
Back
Back
Balance Sheet
source: myfinsight.com
REGENXBIO Inc. (RGNX)
REGENXBIO Inc. (RGNX)